Capital Advisors, Ltd. LLC Biomarin Pharmaceutical Inc Transaction History

Capital Advisors, Ltd. LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 18, 2024	BUY	$83.81 - $99.0 $83 - $99	1 Added 25.0%	5 $0
Q4 2023 Feb 02, 2024	SELL	$76.22 - $98.51 $76 - $98	-1 Reduced 20.0%	4 $0
Q3 2023 Oct 27, 2023	SELL	$85.07 - $94.48 $170 - $188	-2 Reduced 28.57%	5 $0
Q4 2022 Feb 07, 2023	SELL	$80.93 - $108.63 $728 - $977	-9 Reduced 56.25%	7 $1,000
Q3 2022 Nov 09, 2022	BUY	$82.16 - $96.94 $1,314 - $1,551	16 New	16 $1,000
Q1 2022 May 09, 2022	SELL	$74.28 - $92.69 $74 - $92	-1 Closed	0 $0
Q4 2021 Feb 08, 2022	BUY	$71.72 - $91.47 $71 - $91	1 New	1 $0

637

177M

2.01M

1.28M

Ticker BMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,824,000
Market Cap $12.4B
Description
BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...

Get notified when there are updates to the investment portfolio of Capital Advisors, Ltd. LLC, based on Form 13F filings with the SEC.

Stay updated on Capital Advisors, Ltd. LLC with notifications on news.